Invited Speakers

Keynote Speaker

Koichi TanakaShimadzu Corporation, JapanKS: Applications of Mass Spectrometry in Laboratory Medicine

Laboratory medicine commonly requires analytical instruments that can quickly, easily, and inexpensively identify compounds and their forms associated with diseases with the highest sensitivity, quantitative performance, and specificity using minimally invasive techniques. Advancements in technical innovation for mass spectrometers (MS) have now led to techniques that meet such requirements.Besides identifying known substances, other purposes and advantages of MS that are not well known to the public include using MS as a tool to discover unknown phenomena and compounds. An example is clarifying the mechanisms of human diseases. The human body has approximately 100 thousand types of proteins, and there may be more than 10 million types of post-translationally modified proteins and their metabolites. Most of them have yet to be discovered and their discovery may give birth to new academic fields and lead to a better understanding of diseases, development of new drugs, and other advancements.For example, using the MS system developed under “Contribution to drug discovery and diagnosis by next generation of advanced mass spectrometry system,” one of the 30 projects funded by the “Funding Program for World-Leading Innovative R&D on Science and Technology” (FIRST program), and using other individual elemental and basic technologies, we succeeded in discovering new disease biomarker candidates, such as for Alzheimer’s disease and cancers.Further contributions by MS to laboratory medicine can be expected through the development and improvement of new techniques, efforts to verify discoveries, and through multidisciplinary communication, especially with researchers and engineers directly involved in using instruments for medical applications.

Abstract

Dr. Koichi Tanaka was awarded the Nobel Prize in Chemistry in 2002, for developing mass spectrometric analyses of biological macromolecules utilizing soft lasers. He is also recognized for his distinguished services in the field of culture, and is a recipient of the Order of Cultural Merit.Dr. Tanaka will deliver the keynote speech at this year’s World Congress. He is currently working on the practical application of technology for the “early detection of disease, using a single drop of blood.”Dr. Tanaka is a Senior Fellow at Shimadzu Corporation and the head of Koichi Tanaka Mass Spectrometry Research Laboratory, as well as the head of the Koichi Tanaka Laboratory of Advanced Science and Technology.

Special Lecturers

Hayato MiyachiTokai University School of Medicine, Department of Laboratory Medicine, JapanSL01: Challenges and Prospects for International Standardization of

Molecular-genetic Testing in the Era of Genomic Medicine

Yu Chu Su1,2

1 Department of Laboratory Medicine, National Taiwan University Hospital, Taiwan

2 Institute of Biomedical Engineering, National Taiwan UniversitySL02: Bridging the gap between Clinical Medicines and Laboratory

Medicine on the Urine Sediment Microscopy

Michael OellerichUniversity Medicine Göttingen (UMG), Institute for Clinical Pharmacology, GermanyIL02: Circulating cell-free DNA as a diagnostic tool in transplantation

and cancer

Per Erlend HasvoldWorld Health Organization, SwitzerlandIL03: Mobile and digital health to support Universal Health Care and

the Sustainable Development Goal

Invited Lecturers

Jennifer YoungDirector, International Strategy and Operations, American Society for Clinical Pathology, United StatesIL01: HPV DNA Testing in Primary Cervical Cytology Screening: The

Controversies in its Clinical Applications

Educational Lecturers

Chuan-Liang KaoDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, TaiwanEL01-1: Laboratory Diagnosis of Dengue Fever Diseases: Current and Future

Perspectives

Patrick Joseph ChattadFIMLS, CameroonEL01-2: Strengthening Laboratory Capacity in Africa.

Maureen EllisInternational Federation of Biosafety Associations, CanadaEL01-3: New Professional Certification Program for Laboratory Biosafety Professionals

Chitose Inoue, Yoshiharu SuzukiJapanese Red Cross Kanto-Koshinetsu Block Blood Center, JapanEL02-1: The approach for the safety of serological screening tests

Hideto OgawaJapanese Red Cross Kinki Block Blood Center, JapanEL02-2: Safety Measures to Blood for Transfusion implemented in the Blood Preparation

Process: Leukocyte Reduction, Irradiation and Visual Inspection

Henriette L MichelsenSørlandet sykehus Kristiansand, NorwayEL02-3: Experiences regarding usage of apheresis in a small blood bank –How to get

the best utilization of blood donors using apheresis–

Leila Lany Florento1,2

1 United Laboratories, Inc., Philippines 2 The Philippine Association of Medical Technologists, Inc. (PAMET)EL03-1: Standardization of Cytomorphologic Judgement and Training in Clinical

Laboratory

Takako TamuraDepartment of Blood Tests, Clinical Laboratory, Tokyo Women’s Medical University Hospital, JapanEL03-2: Microscopy quality control and an associated education system at our hospital

blood laboratory

Minji Yoon, M.T.1, Sun-Hee Jun, M.T.1, Kyunghoon Lee, M.D.1,2, Sang Hoon Song, M.D.2, and Junghan Song, M.D.1,2 1 Department of Laboratory Medicine, Seoul National University Bundang Hospital,

Seongnam, Korea2 Department of Laboratory Medicine, Seoul National University College of Medicine,

Seoul, KoreaEL04-1: Performance Evaluation of Liquid Chromatography-Tandem Mass Spectrometry

as Confirmatory Tests for Drugs of Abuse from Urine Samples

Mamoru SatohDivision of Clinical Mass Spectrometry, Chiba University Hospital, JapanEL04-2: The role of mass spectrometry in clinical laboratory: focusing on vitamin D testing

Symposiasts

Shinji Matsumoto, Katsumi Kobata, Makoto Hamasaki, Kazuki NabeshimaDepartment of Pathology, Fukuoka University Hospital, JapanSY01-1: Morphology of 9p21 Homozygous Deletion-Positive Pleural Mesothelioma Cells

Analyzed Using FISH and Virtual Microscope System in Effusion Cytology

Fernando Mendes1,2,3,4, Ana Margarida Abrantes1,3, Cátia Domingues3,5, Paulo Rodrigues-Santos3,6,7,8, Ana Cristina Gonçalves3,5, Tiago Sales1, Rita Silva1, Jéssica Estrela2, João Encarnação1, Ana Salome Pires1,3,4, Mafalda Laranjo1,3,4, Vera Alves6, Ricardo Teixo1, Ana Bela Sarmento3,5,7, Maria Filomena Botelho1,3, Manuel Santos Rosa6

1 Biophysics and Biomathematics Institute, IBILI-Faculty of Medicine, University of Coimbra, Portugal

2 Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department Biomedical Laboratory Sciences, Coimbra, Portugal

3 CIMAGO, FMUC-Faculty of Medicine, University of Coimbra, Portugal 4 CNC.IBILI, Universidade de Coimbra, Portugal 5 Applied Molecular Biology and Clinical University of Hematology, Faculty of Medicine of

University of Coimbra, Coimbra, Portugal 6 Immunology Institute, Faculty of Medicine, University of Coimbra, Coimbra, Portugal 7 Hematology Clinic Department Centro Hospitalar Universitário de Coimbra, Coimbra,

Portugal 8 Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology,

University of Coimbra, Coimbra PortugalSY01-2: Characterization of cellular and molecular radiation effects in cancer –

Experimental study in lymphoma and small cell lung cancer–

Mirjana Stupnisek1,2, Ivan Milas1,3

1 Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia2 University Hospital for Infectious Diseases „Dr. Fran Mihaljevic“, Zagreb, Croatia3 University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb,

CroatiaSY01-3: THE ROLE OF LABORATORY MEDICINE IN DIAGNOSIS, TREATMENT AND

MONITORING OF BREAST CANCER

Berit W. RevaaDepartment of Pathology, Vestfold Hospital Trust, NorwaySY01-4: Quality assurance of staining in the histology laboratory

Wen-Shyang HsiehPresident, Taiwan Society of Laboratory Medicine, TaiwanSY02-1: Explore the Possibility of POCT

Mitsuaki NagasawaDepartment of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, JapanSY02-2: Usefulness of POCT at the time of the disaster

Kaoru TerashimaFujifilm Corporation, JapanSY02-3: POCT as a global health

Martina Jursdbio - Danish Association of Biomedical Laboratory Scientists, DenmarkSY02-4: How to improve local citizen-centered healthcare services using new diagnostic

and laboratory solutions

Keiko InomataDepartment of Clinical Laboratory, Yamashita Thyroid & Parathyroid Clinic, JapanSY03-1: Immunological and Histopathological Analysis of Gravesá Disease Patients with

or without IgG4 positive Cell Rich Infiltration

Aki Nakayama HowleyBunkyo Gakuin University, JapanSY03-2: Urinary exosomes: the future of biomarkers in renal disease

Claudia Finocchi, Elisa De VitisANTeL-Assiatel/AITIC, ItalySY03-3: Newborn screening for primary immunodeficiencies –A quicker diagnosis by

screening test for a better state of health–

Joseph NdarubweinePrograms, TASO Uganda, Uganda Laboratory Technology Association (UMLTA)SY03-4: Seroprevalence and risk factors associated with Toxoplasmosis among HIV

positive patients at TASO Entebbe, Uganda Detection of Toxoplasma gondii using Rapid Testing Kits and ELISA Toxoplasma

IgG and IgM Kits at TASO Entebbe, Uganda

Kazumasa IsobeLaboratory Medicine, Institute of Clinical Medicine, Tsukuba University, JapanSY04-1: Precollection and collection –Not only analytical but also preanalytical–

Marie N RoaldNITO The Norwegian Institute of Biomedical Science, Oslo, Norway SY04-2: Applied ethics for Biomedical Laboratory Scientists –Use of ethical reflection

models as a systematic approach to ethical dilemmas–

Mie NagatsukaSatellite Laboratory Planning and Coordination Center, Clinical Laboratory Business Segment , LSI Medience corporation, JapanSY04-3: Specimen storage and transportation – Circumstance surrounding pre-analytical

quality assurance at a Japanese clinical testing company. –

Nau Ishimine1, Kenji Kawasaki1, Yoko Usami1, Kazuhiro Nagata1, Mitsutoshi Sugano1,Takayuki Honda2

1 Department of Laboratory Medicine, Shinshu University Hospital, Japan 2 Department of Laboratory Medicine, Shinshu University school of MedicineSY05-1: Real-Time Reaction Trace system on JCA-BM Analyzers

Yoshikazu Yamamoto1, Shuji Matsuo1, Noriko Hatanaka1, Kumiko kamihara2, Tomonori Mimura2, Akihiro Iguchi2

1 Tenri Health Care University, Japan 2 Hitachi High-Technologies CorporationSY05-2: Reliability assurance of individual measurements and detection of any unusual

reactions based on the Reaction Curve Fitting Method

Nilrat WannasilpDepartment of Clinical Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, ThailandSY05-3: Pitfalls in Utilization of HbA1c in SEA patients

Mitsuko Maruyama1, Koji Yamamoto2, Makoto Okuda3

1 Division of Blood Transfusion, Mie University hospital, Japan 2 Saiseikai Matsusaka General Hospital 3 Toho University Omori Medical CenterSY06-1: Reflections on clinical education about pre-transfusion testing

Ji-sang Kang1, Young-kuk Kwak1, Kyou-sup Han2

1 Laborotory Medicine, Seoul National University Hospital, Korea 2 Laborotory Medicine, Seoul National University CollegeSY06-2: The Frequency of Unexpected Antibodies at the Seoul National

University Hospital in Recent 3 Years

SUK WON SEO, HOI JOO YANG, SEOG WOON KWONAsan Medical Center, Dept of Laboratory Medicine, KoreaSY06-3: Isoagglutinin Titer for ABO-Incompatible Living Donor Liver Transplantation

Shyh-Chyi LoDepartment of Laboratory Medicine, National Taiwan University Hospital, Taipei, TaiwanSY06-4: Blood safety and pretransfusion testing

Ryunosuke Ohkawa, Minoru TozukaTokyo Medical and Dental University, JapanSY07-1: ¨What Is and How to Make Leader of Biomedical Laboratory Scientist

Alan WainwrightInstitute of Biomedical Science, United KingdomSY07-2: Options for Delivering Biomedical Scientist Education and Training

Marie Culliton1,2

1 European Association for Professions in Biomedical Sciences, Brussels, Belgium, Ireland 2 The Academy of Clinical Science and Laboratory Medicine, Dublin, IrelandSY07-3: Educating Biomedical Scientists for the Future.

Catherine OttoShoreline Community College, United StatesSY08-1: Improving Diagnoses--The Role of the Biomedical Laboratory Scientist

Shigeki MisawaDepartment of Clinical Laboratory Medicine, Juntendo Univeristy Hospital, JapanSY08-2: Infection control and medical technologist in Japan

Kyoko Komatsu1,2

1 PAST President of IFBLS2 Cancer Institute Hospital of JFCR, JapanSY08-3: Management for Pathology and Cytology Laboratory

―From the View point of Patient first―

Sayoko KawakamiLaboratory of Antimicrobial Agents and Resistance Department of Bacteriology 2, National institute of Infection Diseases, Japan SY09-1: Detection of carbapenem-resistant Enterobacteriaceae and issues to overcome

Jiunn-Jong WuDepartment of Biotechnology and Laboratory Science in Medicine Yang-Ming University, Taiwan SY09-2: Outer membrane protein C of Escherichia coli in carbapenem-resistance and

bacterial virulence

Katsunori YanagiharaNagasaki University, JapanSY09-3: Trends of Carbapenem-Resistant Enterobacteriaceae and Its Detection

Techniques

Case Conference Speaker

Fumihiko Ookubo1, Yutaka Koga1,2, Yoshihiro Ohishi1,2, Yoshinao Oda1,2

1 Division of Diagnostic Pathology, Kyushu University Hospital, Japan2 Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical

Sciences, Kyushu University, JapanCC01-1: Case presentation

Junzo FujiyamaDepartment of Cytology, Cancer Institute Hospital, JapanCC01-2: Cytology of uterine cervix

Hwa-jeong Ha, Jung-soon Kim, Seung-sook Lee, Jae-soo KohDepartment of Pathology, Korea Cancer Center Hospital, KoreaCC01-3: Fine needle aspiration cytology of lung mass

Chun-Ming Wang, Tsu-Yao Cheng, Ya-Ting Lee, Ping-Fung Chung, Min-Se Huang, Ming-Hsiang Weng, I-Shiow Jan, Sow-Hsong KuoDepartment of Laboratory Medicine, National Taiwan University Hospital, TaiwanCC01-4: Diagnostic pitfalls in breast fine-needle aspiration (FNA) cytology of sclerosing

adenosis

Aya OganeThe University of Tokyo Hospital, JapanCC02-1: Case 1

Yuki OhkawaOkinawa Red Cross Hospital, JapanCC02-2: Case 2

Hyun-A LEE, Ji-Hye PARK, Myung-Hyun NAM, Soo-Young YOONDepartment of Laboratory Medicine, Korea University Medical Center, KoreaCC02-3: COMPARISON OF MEASUREMENTS IN THE TWO POSITIONS AND

SUITABILITY OF ERROR MESSAGE OF THE PFA-100

Thursday, September 1, 2016Kobe International Conference Center 3F Room 301

Invited Lecture 1 13:30-14:30

Chair: Kyoko Komatsu(Cancer Institute Hospital, Japan)

IL01 HPVDNATestinginPrimaryCervicalCytologyScreening:TheControversiesinitsClinicalApplicationsJennifer YoungDirector, International Strategy and Operations, American Society for Clinical Pathology, United States

Special Lecture 1 14:30-15:30

Molecular DiagnosisChair: Hiromitsu Yokota(Toho University, Japan)

SL01 ChallengesandProspectsforInternationalStandardizationofMolecular-geneticTestingintheEraofGenomicMedicineHayato MiyachiTokai University School of Medicine, Department of Laboratory Medicine, Japan

Special Lecture 2 15:30-17:00

UrinalysisChair: Haruhito Kikuchi(Department of Laboratory Medicine, School of Medicine, Keio University,

Japan)

SL02 BridgingthegapbetweenClinicalMedicinesandLaboratoryMedicineontheUrineSedimentMicroscopyYu Chu Su1,2

1 Department of Laboratory Medicine, National Taiwan University Hospital, Taiwan2 Institute of Biomedical Engineering, National Taiwan University

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Thursday, September 1, 2016Kobe International Exhibition Hall 2 2F Room 2A

Educational Lecture 1TopicalInfectiousDiseasesandLaboratoryDiagnosis 11:00-12:00

MicrobiologyChair: Kosuke Haruki(Department of Laboratory Medicine, Dokkyo Medical University Koshigaya

Hospital, Japan)

EL01-1 LaboratoryDiagnosisofDengueFeverDiseases:CurrentandFuturePerspectivesChuan-Liang KaoDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taiwan, ROC, Taiwan

EL01-2 StrengtheningLaboratoryCapacityinAfrica.Patrick Joseph ChattadFIMLS, Cameroon

EL01-3 NewProfessionalCertificationProgramforLaboratoryBiosafetyProfessionalsMaureen EllisInternational Federation of Biosafety Associations, Canada

Symposium 2ExplorethePossibilityofPOCT 13:30-15:00

Clinical ChemistryChair: Susumu Osawa(Department of Medical Science Technology, International University of

Health and Welfare, Japan)

SY02-1 ExplorethePossibilityofPOCTWen-Shyang HsiehPresident, Taiwan Society of Laboratory Medicine, Taiwan

SY02-2 UsefulnessofPOCTatthetimeofthedisasterMitsuaki NagasawaDepartment of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Japan

SY02-3 POCTasaglobalhealthKaoru TerashimaFujifilm Corporation, Japan

SY02-4 Howtoimprovelocalcitizen-centeredhealthcareservicesusingnewdiagnosticandlaboratorysolutionsMartina Jursdbio - Danish Association of Biomedical Laboratory Scientists, Denmark

Thursday, September 1, 2016Kobe International Exhibition Hall 2 2F Room 2A

Symposium 5UsefulnessofAbnormalReactionDetectionSystemofBiochemicalAnalyzer 15:30-17:00

Clinical ChemistryChair: Masanori Seimiya(School of Health Sciences at Narita, International University of Health and

Welfare, Japan)

SY05-1 Real-TimeReactionTracesystemonJCA-BMAnalyzersNau Ishimine1, Kenji Kawasaki1, Yoko Usami1, Kazuhiro Nagata1, Mitsutoshi Sugano1, Takayuki Honda2

1 Department of Laboratory Medicine, Shinshu University Hospital, Japan2 Department of Laboratory Medicine, Shinshu University school of Medicine

SY05-2 ReliabilityassuranceofindividualmeasurementsanddetectionofanyunusualreactionsbasedontheReactionCurveFittingMethodYoshikazu Yamamoto1, Shuji Matsuo1, Noriko Hatanaka1, Kumiko Kamihara2, Tomonori Mimura2, Akihiro Iguchi2

1 Tenri Health Care University, Japan2 Hitachi High-Technologies Corporation

SY05-3 PitfallsinUtilizationofHbA1cinSEApatientsNilrat WannasilpDepartment of Clinical Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Thursday, September 1, 2016Kobe International Exhibition Hall 2 2F Room 2B

Educational Lecture 2SafetyScreeningTestsofDonor'sBloodSamplesandSafetyMeasuresofBloodProductsintheManufacturingProcess 11:00-12:00

Transfusion MedicineChair: Yoshihiro Bouike(Faculty of Nutrition, Kobe Gakuin University, Japan)

EL02-1 TheapproachforthesafetyofserologicalscreeningtestsChitose Inoue, Yoshiharu SuzukiJapanese Red Cross Kanto-Koshinetsu Block Blood Center, Japan

EL02-2 SafetyMeasurestoBloodforTransfusionimplementedintheBloodPreparationProcess:LeukocyteReduction,IrradiationandVisualInspectionHideto OgawaJapanese Red Cross Kinki Block Blood Center, Japan

EL02-3 Experiencesregardingusageofapheresisinasmallbloodbank-Howtogetthebestutilizationofblooddonorsusingapheresis-Henriette L MichelsenSørlandet sykehus Kristiansand, Norway

Symposium 3CurrentSituationandFutureProspectofImmunology 13:30-15:00

ImmunologyChair: Nobuo Okumura(Laboratory of Clinical Chemistry and Immunology, Department of Biomedical

Laboratory Sciences, School of Health Sciences, Shinshu University, Japan) Katsuji Shimoda(Japanese Association of Medical Technologists, Japan)

SY03-1 ImmunologicalandHistopathologicalAnalysisofGraves'DiseasePatientswithorwithoutIgG4PositiveCellRichInfiltrationKeiko InomataYamashita Thyroid & Parathyroid Clinic, Japan

SY03-2 Urinaryexosomes:thefutureofbiomarkersinrenaldiseaseAki Nakayama HowleyBunkyo Gakuin University, Japan

SY03-3 Newbornscreeningforprimaryimmunodeficiencies-Aquickerdiagnosisbyscreeningtestforabetterstateofhealth-Claudia Finocchi, Elisa De VitisANTeL-Assiatel/AITIC, Italy

SY03-4 SeroprevalenceandriskfactorsassociatedwithToxoplasmosisamongHIVpositivepatientsatTASOEntebbe,UgandaDetectionofToxoplasmagondiiusingRapidTestingKitsandELISAToxoplasmaIgGandIgMKitsatTASOEntebbe,UgandaJoseph Ndarubweine, Polly Rwandekeye, Josephine LunkusePrograms, TASO Uganda, Uganda Laboratory Technology Association (UMLTA), Uganda

Thursday, September 1, 2016Kobe International Exhibition Hall 2 3F Room 3A

Symposium 1CurrentTopicsofPathologyandCytology 10:30-12:00

Pathology & CytologyChair: Tadao Kobayashi(Division of Health Sciences, Osaka University Graduate School of

Medicine, Japan)

SY01-1 Morphologyof9p21HomozygousDeletion-PositivePleuralMesotheliomaCellsAnalyzedUsingFISHandVirtualMicroscopeSysteminEffusionCytologyShinji Matsumoto, Katsumi Kobata, Makoto Hamasaki, Kazuki NabeshimaDepartment of Pathology, Fukuoka University Hospital, Japan

SY01-2 CharacterizationofcellularandmolecularradiationeffectsincancerExperimentalstudyinlymphomaandlungcancerFernando Mendes1,2,3,4, Ana Margarida Abrantes1,3, Cátia Domingues3,5, Paulo Rodrigues-Santos3,6,7,8, Ana Cristina Gonçalves3,5, Tiago Sales1, Rita Silva1, Jéssica Estrela2, João Encarnação1, Ana Salome Pires1,3,4, Mafalda Laranjo1,3,4, Vera Alves6, Ricardo Teixo1, Ana Bela Sarmento3,5,7, Maria Filomena Botelho1,3, Manuel Santos Rosa6

1 Biophysics and Biomathematics Institute, IBILI-Faculty of Medicine, University of Coimbra, Portugal

2 Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department Biomedical Laboratory Sciences, Coimbra, Portugal

3 CIMAGO, FMUC-Faculty of Medicine, University of Coimbra, Portugal4 CNC.IBILI, Universidade de Coimbra, Portugal5 Applied Molecular Biology and Clinical University of Hematology, Faculty of Medicine of

University of Coimbra, Coimbra, Portugal6 Immunology Institute, Faculty of Medicine, University of Coimbra, Coimbra, Portugal7 Hematology Clinic Department Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal8 Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology, University

of Coimbra, Coimbra Portugal

SY01-3 THEROLEOFLABORATORYMEDICINEINDIAGNOSIS,TREATMENTANDMONITORINGOFBREASTCANCERMirjana Stupnisek1,2, Ivan Milas1,3

1 Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia2 University Hospital for Infectious Diseases „Dr. Fran Mihaljevic“, Zagreb, Croatia3 University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

SY01-4 QualityassuranceofstaininginthehistologylaboratoryBerit W. RevaaDepartment of Pathology, Vestfold Hospital Trust, Norway

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Thursday, September 1, 2016Kobe International Exhibition Hall 2 3F Room 3A

Symposium 4EffectsonLaboratoryTestResultsbyErrorsandVariablesinthePre-AnalyticalPhase 13:30-15:00

Laboratory ManagementChair: Yui Namikawa(Department of Medical Technology, Faculty of Biomedical Engineering, Toin

University of Yokohama, Japan) Edward Welsh(IFBLS Board Member, United Kingdom)

Assistant Chair: Hiromitsu Yokota(Toho University, Japan)

SY04-1 Precollectionandcollection-Notonlyanalyticalbutalsopreanalytical-Kazumasa IsobeLaboratory Medicine, Institute of Clinical Medicine, Tsukuba University, Japan

SY04-2 AppliedethicsforBiomedicalLaboratoryScientists-Useofethicalreflectionmodelsasasystematicapproachtoethicaldilemmas-Marie N RoaldNITO The Norwegian Institute of Biomedical Science, Oslo, Norway

SY04-3 Specimenstorageandtransportation-Circumstancesurroundingpre-analyticalqualityassuranceataJapaneseclinicaltestingcompany.-Mie NagatsukaSatellite Laboratory Planning and Coordination Center, Clinical Laboratory Business Segment, LSI Medience corporation, Japan

Symposium 6BloodSafetyforPre-TransfusionTesting 15:30-17:00

Transfusion MedicineChair: Misa Sakamoto(Sysmex Corporation, Japan)

SY06-1 Reflectionsonclinicaleducationaboutpre-transfusiontestingMitsuko Maruyama1, Koji Yamamoto2, Makoto Okuda3

1 Division of Blood Transfusion, Mie University Hospital, Japan2 Saiseikai Matsusaka General Hospital3 Toho University Omori Medical Center

SY06-2 TheFrequencyofUnexpectedAntibodiesattheSeoulNationalUniversityHospitalinRecent3YearsTheFrequencyandcaseofUnexpectedAntibodiesattheSNUHduringrecent3Years(March2012-February2015)Ji-sang Kang1, Young-kuk Kwak1, Kyou-sup Han2

1 Laboratory Medicine, Seoul National University Hospital, Korea2 Laboratory Medicine, Seoul National University College

SY06-3 IsoagglutininTiterforABO-IncompatibleLivingDonorLiverTransplantationSUK WON SEO, HOI JOO YANG, SEOG WOON KWONAsan Medical Center, Dept of Laboratory Medicine, Korea

SY06-4 BloodsafetyandpretransfusiontestingShyh-Chyi LoDepartment of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Thursday, September 1, 2016Kobe International Exhibition Hall 2 3F Room 3B

Case Conference 2InteractiveCaseConference 15:30-17:00

HematologyChair: Yoko Tabe(Department of Clinical Laboratory Medicine, Juntendo Univeristy Hospital,

Japan) Chiaki Ikeda(Department of Clinical Laboratory, Toranomon Hospital, Japan)

CC02-1 Case1Aya OganeThe University of Tokyo Hospital, Japan

CC02-2 Case2Yuki OhkawaOkinawa Red Cross Hospital, Japan

CC02-3 COMPARISONOFMEASUREMENTSINTHETWOPOSITIONSANDSUITABILITYOFERRORMESSAGEOFTHEPFA-100Hyun-A LEE, Ji-Hye PARK, Myung-Hyun NAM, Soo-Young YOONDepartment of Laboratory Medicine, Korea University Medical Center, Korea

Friday, September 2, 2016Kobe International Exhibition Hall 2 2F Room 2A

Symposium 7HowtoMakeNextGenerationBiomedicalLaboratoryScientists 09:30-11:00

EducationChair: Hideo Sakamoto(Department of Medical Technology, Faculty of Health Sciences, Kobe

Tokiwa University, Japan) Gry Andersen(Diagnostic Services, UNN HF, Norway)

SY07-1 ¨WhatIs¨and¨HowtoMake¨LeaderofBiomedicalLaboratoryScientist?Ryunosuke Ohkawa, Minoru TozukaTokyo Medical and Dental University, Japan

SY07-2 OptionsforDeliveringBiomedicalScientistEducationandTrainingAlan WainwrightInstitute of Biomedical Science, United Kingdom

SY07-3 EducatingBiomedicalScientistsfortheFuture.Marie Culliton1,2

1 European Association for Professions in Biomedical Sciences, Brussels, Belgium2 The Academy of Clinical Science and Laboratory Medicine, Dublin, Ireland

Educational Lecture 3StandardizationofCytomorphologicJudgementandTraininginClinicalLaboratory 13:30-14:30

HematologyChair: Hiroshi Kondo(Kansai University of Health Science, Japan)

Eddie Han Sans(Singapore Association for Medical Laboratory Sciences, Singapore)

EL03-1 StandardizationofCytomorphologicJudgementandTraininginClinicalLaboratoryLeila Lany Florento1,2

1 United Laboratories, Inc, Philippines2 The Philippine Association of Medical Technologists, Inc. (PAMET)

EL03-2 MicroscopyqualitycontrolandanassociatededucationsystematourhospitalbloodlaboratoryTakako TamuraDepartment of Blood Tests, Clinical Laboratory, Tokyo Women’s Medical University Hospital, Japan

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Friday, September 2, 2016Kobe International Exhibition Hall 2 2F Room 2B

Symposium 8PatientSafetyFirstandInfectionControl 09:30-11:00

Laboratory ManagementChair: Keiko Inoue(Tsukuba i-Laboratory, Japan)

Tom Stowe(IFBLS President, Canada)Assistant Chair: Etsu Suzuki(Tsukuba Medical Laboratory of Education and Research, Japan)

SY08-1 ImprovingDiagnoses--TheRoleoftheBiomedicalLaboratoryScientistCatherine OttoShoreline Community College, United States

SY08-2 InfectionControlandBiomedicalLaboratoryScientistsinJapanShigeki MisawaDepartment of Clinical Laboratory Medicine, Juntendo University Hospital, Japan

SY08-3 ManagementforPathologyandCytologyLaboratory―FromtheViewpointofPatientfirst―Kyoko Komatsu1 PAST President of IFBLS2 Cancer Institute Hospital of JFCR, Japan

Friday, September 2, 2016Kobe International Exhibition Hall 2 3F Room 3A

Symposium 9TrendsofCarbapenem-ResistantEnterobacteriaceaeandItsDetectionTechniques 09:30-11:00

MicrobiologyChair: Masahiro Toyokawa(Department of Laboratory Medicine, Tohoku University Hospital, Japan)

Tatsuya Nakamura(Kobe University Hospital, Japan)

SY09-1 Detectionofcarbapenem-resistantEnterobacteriaceaeandissuestoovercomeSayoko KawakamiLaboratory of Antimicrobial Agents and Resistance Department of Bacteriology 2, National institute of Infection Diseases, Japan

SY09-2 OutermembraneproteinCofEscherichiacoli incarbapenem-resistanceandbacterialvirulenceJiunn-Jong WuDepartment of Biotechnology and Laboratory Science in Medicine Yang-Ming University, Taiwan

SY09-3 TrendsofCarbapenem-ResistantEnterobacteriaceaeandItsDetectionTechniquesKatsunori YanagiharaNagasaki University, Japan

Invited Lecture 3 11:00-12:00

Chair: Kiyoaki Watanabe(Department of Laboratory Medicine, International University of Health and Welfare, Mita Hospital, Japan)

IL03 MobileanddigitalhealthtosupportUniversalHealthCareandtheSustainableDevelopmentGoalsPer Erlend HasvoldWorld Health Organization, Switzerland

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Friday, September 2, 2016Kobe International Exhibition Hall 2 3F Room 3A

Educational Lecture 4MassSpectrometrydidgetofftoaPromisingStartfortheRoutineClinicalLaboratoryTest 13:30-14:30

Advanced Laboratory MedicineChair: Fumio Nomura(Division of Clinical Mass Spectrometry, Chiba University Hospital, Japan)

EL04-1 PerformanceEvaluationofLiquidChromatography-TandemMassSpectrometryasConfirmatoryTestsforDrugsofAbusefromUrineSamplesMinji Yoon, M.T.1, Sun-Hee Jun, M.T.1, Kyunghoon Lee, M.D.1,2, Sang Hoon Song, M.D.2, and Junghan Song, M.D.1,2

1 Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

2 Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea

EL04-2 Theroleofmassspectrometryinclinicallaboratory:focusingonvitaminDtestingMamoru Satoh, Fumio NomuraDivision of Clinical Mass Spectrometry, Chiba University Hospital, Japan

Friday, September 2, 2016Kobe International Exhibition Hall 2 3F Room 3B

Case Conference 1Cytology-SlideConference 09:30-11:00

CytologyChair: Hitoshi Abe(Department of Pathology, Keio University School of Medicine, Japan)

Masami Nanbu(Department of Pathology, Fukuoka University Chikushi Hospital, Japan)

CC01-1 CasepresentationFumihiko Ookubo1, Yutaka Koga1,2, Yoshihiro Ohishi1,2, Yoshinao Oda1,2

1 Division of Diagnostic Pathology, Kyushu University Hospital, Japan2 Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical

Sciences, Kyushu University, Japan

CC01-2 CytologyofuterinecervixJunzo FujiyamaDepartment of Cytology, Cancer Institute Hospital, Japan

CC01-3 FineneedleaspirationcytologyoflungmassHwa-jeong Ha, Jung-soon Kim, Seung-sook Lee, Jae-soo KohDepartment of Pathology, Korea Cancer Center Hospital, Korea

CC01-4 Diagnosticpitfallsinbreastfine-needleaspiration(FNA)cytologyofsclerosingadenosisChun-Ming Wang, Tsu-Yao Cheng, Ya-Ting Lee, Ping-Fung Chung, Min-Se Huang, Ming-Hsiang Weng, I-Shiow Jan, Sow-Hsong KuoDepartment of Laboratory Medicine, National Taiwan University Hospital, Taiwan

Invited Lecture 2CirculatingCell-freeDNAasaDiagnosticToolinTransplantationandCancer 13:30-14:30

Advanced Laboratory MedicineChair: Masami Murakami(Department of Clinical Laboratory Medicine, Gunma University Graduate

School of Medicine, Japan)

IL02 Circulatingcell-freeDNAasadiagnostictoolintransplantationandcancerMichael OellerichUniversity Medicine Göttingen (UMG), Institute for Clinical Pharmacology, Germany

IFBLS2016 The 32nd World Congress of Biomedical Laboratory Science

2016

I FBLSKobe Japan

Friday, September 2, 2016Kobe Portopia Hotel South Wing 1F Portopia Hall

Keynote Speech 16:00-16:45

Advanced Laboratory MedicineChair: Yoshifumi Miyajima(Japanaese Association of Medical Technologists, Japan)

KS ApplicationsofMassSpectrometryinLaboratoryMedicineKoichi TanakaShimadzu Corporation, Japan